Ex Parte Hoffmann et alDownload PDFPatent Trial and Appeal BoardOct 25, 201612182795 (P.T.A.B. Oct. 25, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 12/182,795 07/30/2008 27387 7590 10/25/2016 LONDA, BRUCE S, NORRIS MCLAUGHLIN & MARCUS, PA 875 THIRD A VE, 8TH FLOOR NEW YORK, NY 10022 FIRST NAMED INVENTOR Martin Hoffmann UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 101216-109 4423 EXAMINER PALLAY,MICHAELB ART UNIT PAPER NUMBER 1617 MAILDATE DELIVERY MODE 10/25/2016 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte MARTIN HOFFMANN and CLAUDIA ARBTER Appeal2014-004146 Application 12/182, 795 1 Technology Center 1600 Before JEFFREY N. FREDMAN, RICHARD J. SMITH, and DAVID COTTA, Administrative Patent Judges. COTT A, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134 involving claims to an aqueous composition for conditioning keratin fibers. The Examiner rejected the claims on appeal as obvious under 35 U.S.C. § 103(a). We affirm. 1 The real party in interest is Kao Germany GmbH. Reel/frame 030186/0381; see also App. Br. 2. Appeal2014-004146 Application 12/182,795 STATEMENT OF THE CASE Claims 1-3, 5-7, 9-11, 15, 18, and 20 are on appeal. 2 Claim 1, the only independent claims on appeal, reads as follows: 1. An aqueous composition for conditioning keratin fibres comprising at least one cationic polymer with multiple cationic sites and with multiple ester groups in its molecule, at least one cationic cellulose derivative and at least one cationic silicone compound selected from the group consisting of Quatemium-80 and quatemized graft polymers of organopolysiloxane and polyethyloxazoline, wherein the weight ratio of cationic polymer to cationic cellulose derivative is 0.1: 1 to 2: 1. As the result of a restriction requirement, Appellants elected the following species without traverse: "cationic cellulose derivative polyquatemium-67, cationic silicone compound quatemium-80, cationizable silicone compound amodimethicone, fatty alcohol cetylstearyl alcohol, and emulsifier behentriumonium chloride." Ans. 2. We limit discussion and consideration to the elected species, and take no position respecting the patentability of the broader generic claims, including the remaining, non-elected species. See Ex parte Ohsaka, 2 USPQ2d 1461 (Bd. Pat. App. Int. 1987). The claims stand rejected as follows: Claims 1-3, 5-7, 9-11, 18, and 20 under 35 U.S.C. § 103(a) as 2 Appellants identify claims 8, 13, 14, and 19 as also on appeal. App. Br. 1. These claims were withdrawn from consideration under 37 C.F.R. 1.142(b) as being drawn to nonelected inventions and species. Final Act. 2. Accordingly, we do not consider these claims to be part of this appeal. 2 Appeal2014-004146 Application 12/182,795 , , 1 1 ,1 1 • ,• ,..~ ,• 1. 1 ,1 T TTr'lr-T"iT""'ti.T"""1T"'l>.T T"""1"'1[T"T'llK unpatentao1e over me comomanon or 1naungamJ ana me LU~lKbYLbJVm Brochure. 4 Claims 1-3, 5-7, 9-11, 15, 18, and 20 under 35 U.S.C. § 103(a) as unpatentable over the combination of Brautigam, the LUSTREPLEX™ Brochure, and Lighten. 5 REJECTION OF CLAMS 1-3, 5-7, 9-11, 18, AND 20 OVER BRAUTIGAM AND THE LUSTREPLEX™ BROCHURE The Examiner found that Brautigam discloses conditioning compositions comprising cationic conditioning agents. Final Act. 4. Among the suitable cationic agents disclosed are quatemium 80 (the elected cationic silicone compound) and polyquatemium 10. Id. The Examiner further found that Brautigam teaches that cationic conditioning agents could be used "alone or in combination with each other." Id. The Examiner determined, however, that Brautigam "does not specifically disclose polyquatemium-67 [the elected cationic cellulose derivative] and polyquatemium-70 [a cationic polymer with multiple cationic sites and with multiple ester groups]." Id. at 5. The Examiner found that the LUSTREPLEX™ Brochure taught the "addition of polyquatemium-7 0 and di propylene glycol to 'any shampoo system to create lustrous, healthy-looking hair by controlling the onset of frizz, retaining its natural shine and conditioning the hair."' Id. The LUSTREPLEX™ Brochure also discloses that "LUSTREPLEX (i.e., 3 Brautigam et al., US Patent Publication No. 2005/0152863 Al, published July 14, 2005 ("Brautigam"). 4 LUSTREPLEX™ Brochure, Croda Inc., dated Nov. 7, 2005 ("LUSTREPLEX™ Brochure"). 5 Lighten, US Patent No. 5,007,531, issued Apr. 16, 1991 ("Lighten"). 3 Appeal2014-004146 Application 12/182,795 polyquaternimn-70 and dipropylene glycol) (1 %), polyquaternimn-67 (0.5%), and polyquaternimn-10 (0.2%)[)] are all anionic compatible quaternaries on the market for use as conditioners in shampoo formulations." Id. at 5---6. The Examiner concluded that it would have been obvious to "add the polyquaternium-70 and polyquaternium-67 of 'LUSTREPLEX' to the composition of Brautigam et al., or to add such polyquaternium-70 to the composition of Brautigam et al. and substitute such polyquaternium-67 for the polyquaternium-10 of the composition of Brautigam." Ans. 3. The Examiner concluded that it would have been obvious to do so because it is obvious to combine compositions that are taught to be useful for the same purpose and because Brautigam "specifically teaches that cationic conditioning agents are used in combination with each other." Final Act. 7. Appellants contend that the person of ordinary skill would not be motivated to combine a cationic polymer, cationic cellulose derivative and a cationic silicone compound into a single composition because, "after reading the cited prior art, a skilled artisan would be discouraged from combining all three cationic compounds." App. Br. 6. We agree with the Examiner that it would have been obvious to add polyquaternium 67 and 70 to the composition of Brautigam because Brautigam specifically teaches the addition of cationic polymers (including polyquaternium 10) as conditioning agents, see Brautigam i-fi-1 66 and 67, and because the LUSTREPLEX™ Brochure teaches that polyquaternium 10, 67 and 70 (as well as Guar HTC) are all "anionic compatible quaternaries on 4 Appeal2014-004146 Application 12/182,795 ,1 1 '°'°' 1•,• • 1 ,.. 1 ,• {:. TTTr'lr-T"iT""'ti.T"""1T"'l>.TT"""1"'1[T'T'llK tne mar Ker as conamoners m snampoo rormmanons. ~ Lu~ l KbY Lb JV m Brochure 5. See In re Kerkhoven, 626 F.2d 846, 850 (CCPA 1980) ("It is prima facie obvious to combine two compositions each of which is taught by the prior art to be useful for the same purpose, in order to form a third composition which is to be used for the very same purpose."); see also KSR Int'! Co. v. Teleflex Inc., 550 U.S. at 417 (2007) ("[W]hen a patent 'simply arranges old elements with each performing the same function it had been known to perform' and yields no more than one would expect from such an arrangement, the combination is obvious."). Appellants argue that the LUSTREPLEX™ Brochure teaches away from the claimed combination because it teaches "the detrimental effects of PQ-10 and PQ-67." Reply Br. 3. As evidence, Appellants assert that the LUSTREPLEX™ Brochure's teaches that: • Polyquatemium 67 "displays the same amount of dulling as a control sample that did not contain any cationic polymer;" • Polyquatemium 67 "showed no difference in humidity resistance than the control, which suggests that PQ-67 is completely worthless when it comes to humidity resistance." • Polyquatemium 67 "did not help to maintain the shine of the hair" and ' • Polyquatemium 67 "exhibited noticeable build-up." 6 Appellants do not dispute that it would have been obvious to add polyquatemium 70 to the composition of Brautigam. App. Br. 6 ("[T]he prior art would lead the skilled artisan to combining only a cationic polymer (Polyquatemium-70) with a cationic silicone."). 5 Appeal2014-004146 Application 12/182,795 ~ 1 T""lt. ,.... Al 7 Kep1y tlr. j---4.' We disagree with Appellants that the effects of polyquatemimn 67 are "detrimental" at least with respect to dulling, shine, and humidity resistance. With respect to dulling, the LUSTREPLEX™ Brochure teaches that polyquatemium 67 "displays about the same amount of dulling as the control shampoo." LUSTREPLEX™ Brochure 9. With respect to humidity resistance, the LUSTREPLEX™ Brochure teaches polyquatemium 67 "showed no visual difference from the control." Id. at 7. And with respect to shine retention, the LUSTREPLEX™ Brochure teaches that polyquatemium 67 may not have "help[ ed] maintain the shine of the hair," but its 84% shine retention exceeded the control's 80% shine retention. Id. at 8. Thus, for dulling, shine, and humidity resistance, polyquatemium 67 exhibited no detrimental effects as compared to the control. The LUSTREPLEX™ Brochure does teach that polyquatemium 67 displays a "build-up tendency." It states: The images on the right are the virgin hair tresses treated with 3 cycles of conditioning active shampoo followed Least Moat Ehlild·up LUSTREPLEX>Guar HTl>Polyquatemlum-67> Polyquateri1.1rn-10 Bulld·UP 7 Appellants also cite to evidence regarding the "detrimental effects" of polyquatemium 10. We need not address the LUSTREPLEX™ Brochure's teachings regarding the effects of polyquatemium 10 here because the Examiner did not propose to add polyquatemium 10 to the composition of Brautigam. Rather, the Examiner asserted that it would have been obvious to "add the polyquatemium-70 and polyquatemium-67 of LUSTERPLEX to the composition of Brautigam et al., or to add such polyquatemium-70 to the composition of Brautigham et al. and substitute such polyquatemium-67 for the polyquatemium-lOofthe composition of Brautigam." Ans. 3. Either of these alternatives would satisfy all of the limitations of claim 1 even if polyquatemium 10 - which is disclosed in Brautigam - were omitted. 6 Appeal2014-004146 Application 12/182,795 by 3 wash cycles with the control shampoo. The images show LUSTREPLEX is almost completely washed from the hair fiber indicating it will not build up .... The other active shampoos display a build-up tendency. Id. at 14. Notwithstanding this teaching, we find that the person of ordinary skill in the art would not have been discouraged from using polyquaternium 67. That polyquaternium 67 may be somewhat inferior to polyquaternium 70 with respect to some properties does not render the use of polyquaternium 67 nonobvious. See In re Gurley, 27 F.3d 551, 553 (Fed. Cir. 1994) (finding the use of epoxy obvious even though the art taught "deficiencies of epoxy-impregnated material," noting ''[a] known or obvious composition does not become patentable simply because it has been described as somewhat inferior to some other product for the same use"). This is particularly tnie given that the LUSTREPLEX™ Brochure also teaches that polyquaternium 67 provides benefits. See e.g., id. at 10 (teaching that poiyquaternium 67 reduces the combing force required to detangle unbleached hair by 30%, an amount comparable to the 29% force reduction provided by polyquaternium 70). Appellants argue that the LUSTREPLEX™ Brochure does not teach a single composition comprising both polyquaternium 67 and polyquaternium 70. App. Br. 6. Appellants assert "LUSTREPLEX substitutes Polyquaternium-70 with Polyquaternium-67, suggesting to the skilled artisan that the polymers cannot or should not be used in the same composition." Id. at 7. We disagree. The LUSTREPLEX™ Brochure provides comparative testing information for four separate compositions comprising four different anionic compatible quaternaries. That the four anionic compatible quaternaries were 7 Appeal2014-004146 Application 12/182,795 tested separately does not mean that they cannot be combined and used together. Brautigam expressly teaches that multiple cationic conditioning agents can be combined. See Brautigam i-f 71 ("Cationic conditioning agents are used alone or in combination with each other."); see also id. i-f 69 ("It is also possible to use mixtures of various cationic polymers."). Moreover, Appellants do not point to any specific teaching in the LUSTREPLEX™ Brochure that the four anionic compatible quaternaries cannot be used together. The LUSTREPLEX™ Brochure's silence with respect to combinations of quaternaries should not be taken as teaching away from such combinations. See DyStar Textilfarben GmbH & Co. Deutsch/and KG v. CH Patrick Co., 464 F.3d 1356, 1364 (Fed. Cir. 2006) ("[M]ere failure to discuss immediate use of his leuco indigo solution for dyeing is not the same thing as Brochet stating in his article that ... his leuco indigo solution may only be concentrated in paste form. We will not read into a reference a teaching away from a process where no such language exists."). Accordingly, we affirm the Examiner's rejection of claim 1 as unpatentable over the combination of Brautigam and the LUSTREPLEX™ Brochure. Because they were not argued separately, claims 2, 5-7, 9-11, 18, and 20 fall with claim 1. REJECTION OF CLAMS 1, 2, 5-7, 9-11, 15, 18, AND 20 OVER BRAUTIGAM, LUSTREPLEX™ BROCHURE, AND LIGHTEN Appellants challenge the Examiner's rejection of claims 1, 2, 5-7, 9- 11, 15, 18, and 20 over Brautigam, the LUSTREPLEX™ BROCHURE and Lighten using the same arguments discussed above. App. Br. 9. We affirm the Examiner's rejection of claims 1, 2, 5-7, 9-11, 15, 18, and 20 for the reasons discussed above. 8 Appeal2014-004146 Application 12/182,795 REJECTIONS OF CLAHvI 3 OVER BRAUTIGAivI AND LUSTREPLEXTM BROCHURE ALONE OR WITH LIGHTEN The Appeal brief includes a separate section addressing the Examiner's rejection of claim 3 over the combination of Brautigam and the LUSTREPLEX™ Brochure. It also includes a separate section addressing the Examiner's rejection of claim 3 over the combination of Brautigam, the LUSTREPLEX™ Brochure, and Lighten. Both of these sections, however, simply incorporate the arguments discussed above. App. Br. 9. We do not find these arguments persuasive for the reasons already discussed. SUMMARY For these reasons and those set forth in the Examiner's Answer, the rejections of claims 1-3, 5-7, 9-11, 15, 18, and 20 are affirmed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § l.136(a)(l). AFFIRMED 9 Copy with citationCopy as parenthetical citation